Christopher Peetz
Overview
Christopher Peetz received an average of $5M in total compensation, including $571K in salary, at Mirum Pharmaceuticals from 2019 to 2023.
2023Mirum PharmaceuticalsChief Executive Officer
2022Mirum PharmaceuticalsPresident and Chief Executive Officer
2021Mirum PharmaceuticalsPresident and Chief Executive Officer
2020Mirum PharmaceuticalsChief Executive Officer and President
2019Mirum PharmaceuticalsChief Executive Officer and President
Source: SEC filings on April 23, 2024, May 1, 2023, April 22, 2022, and April 14, 2021.
Related executives
We found six more executives who work or worked at Mirum Pharmaceuticals.
Eric Bjerkholt
Mirum Pharmaceuticals
Chief Financial Officer
Peter Radovich
Mirum Pharmaceuticals
Chief Operating Officer
Lara Longpre
Mirum Pharmaceuticals
Chief Development Officer
Pamela Vig
Mirum Pharmaceuticals
Head of Research and Development
Ian Clements
Mirum Pharmaceuticals
Chief Financial Officer
Edwin Tucker
Mirum Pharmaceuticals
Chief Medical Officer
News
Mirum Pharmaceuticals CEO Christopher Peetz's 2023 pay jumps 47% to $6.5M
April 23, 2024
Mirum Pharmaceuticals CEO Christopher Peetz's 2022 pay rises 7% to $4.4M
May 1, 2023
Mirum Pharmaceuticals CEO Christopher Peetz's 2021 pay jumps 38% to $4.1M
April 22, 2022
Mirum Pharmaceuticals CEO Christopher Peetz's 2020 pay falls 52% to $3M
April 14, 2021